Related Experiment Video
Updated: Aug 11, 2026
09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Short stature and body proportion in thalassaemia
M Caruso-Nicoletti1, V De Sanctis, M Capra
1Department of Pediatrics, University of Catania, Italy.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|March 26, 1999
Summary
Beta-thalassaemia major patients often experience short stature and disproportionate body growth. Spinal growth impairment, starting in infancy, contributes to a short trunk, with siderosis and endocrine issues potentially worsening disproportion.
Area of Science:
- Pediatrics
- Genetics
- Endocrinology
Background:
- Short stature and trunk disproportion are observed in patients with beta-thalassaemia major.
- Understanding the underlying causes and progression of these growth abnormalities is crucial.
Purpose of the Study:
- To investigate the natural history of short stature and body disproportion in beta-thalassaemia major.
- To determine the roles of siderosis, deferoxamine (DFX) toxicity, and endocrine disorders in these growth patterns.
Main Methods:
- Analysis of auxological and hematological data from 476 patients (2-36 years old) with beta-thalassaemia major.
- Data collected included standing height, sitting height, leg length, target height, transfusion history, DFX treatment details, ferritin levels, and endocrine/bone lesion information.
- Data were analyzed based on patient age to understand growth patterns over time.
Main Results:
- Approximately 18% of patients exhibited short stature.
- 14% showed disproportion between upper and lower body segments.
- A significant 40% presented with a short trunk despite normal stature, attributed to progressive spinal growth impairment starting in infancy.
Conclusions:
- Short trunk is a characteristic feature of beta-thalassaemia major, likely stemming from intrinsic disease processes.
- Factors such as hypogonadism, siderosis, and DFX-induced bone dysplasia may exacerbate body disproportion in these patients.
Related Concept Videos
01:18Polygenic Traits
When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
01:10Nature and Nurture
Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:09Changes in the Appendicular Skeleton with Age
The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...